iron sucrose


BioRx Pharma Labs


Concise Prescribing Info
Fe sucrose
Fe deficiency anemia in patients undergoing chronic hemodialysis who are receiving supplemental erythropoietin therapy.
Dosage/Direction for Use
Individualised dosage according to the total Fe deficit. Adult & elderly Total single dose must not exceed 200 mg of Fe given not more than 3 times/wk.
Hypersensitivity. Anemias not attributable to Fe deficiency. Fe overload or disturbance in utilization of Fe. Patients w/ history of asthma, eczema or other atopic allergy. Pregnancy (1st trimester).
Special Precautions
Allergic or anaphylactoid reactions, loss of consiousness, collapse & hypotension. Avoid in patients w/ hepatic dysfunction where Fe overload is a precipitating factor, in particular Porphyria cutanea tarda (PCT). Periodic monitoring of hematologic & anti-anemia parameters (Hb, hematocrit, serum ferritin & transferrin saturation). W/held therapy in patients w/ evidence of Fe overload. Acute or chronic infection. Paravenous leakage. Lactation, Childn. Elderly.
Adverse Reactions
Transient taste perversions (in particular metallic taste), hypotenslon,fever & shivering, inj site reactions & nausea.
Drug Interactions
Reduced absorption of oral Fe prep.
ATC Classification
B03AC - Iron, parenteral preparations ; Used in the treatment of anemia
Biorose soln for inj 100 mg/5 mL
5 mL x 5 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in